Correction to: Weight change and cardiovascular disease incidence in breast cancer survivors: a nationwide cohort study (Breast Cancer Research and Treatment, (2025), 210, 3, (583-593), 10.1007/s10549-024-07594-2)

In the sentence beginning “Our findings underscore …” in the Discussion section of this article, the citations to the references 57–68 appeared incorrectly. The respective citations and their corresponding references listed below are now deleted from the article. The correct sentence should read as “Our findings underscore the importance of preventing weight gain in this population to mitigate the risk of CVD” instead of “Our findings underscore the importance of preventing weight gain in this population to mitigate the risk of CVD [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [63].” 57. Castro AM, Macedo-de la Concha LE, Pantoja-Meléndez CA (2017) Low-grade inflammation and its relation to obesity and chronic degenerative diseases. Rev Méd Hosp Gen México 80(2):101–105 58. Global BMIMC, Di Angelantonio E, Bhupathiraju ShN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, Cairns BJ, Huxley R, Jackson ChL et al (2016) Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 388(10,046):776–786 59. Janszky I, Romundstad P, Laugsand LE, Vatten LJ, Mukamal KJ, Mørkedal B (2016) Weight and weight change and risk of acute myocardial infarction and heart failure—the HUNT study. J Intern Med 280(3):312–322 60. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R (2009) Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 373(9669):1083–1096 61. Larsson SC, Bäck M, Rees JMB, Mason AM, Burgess S (2020) Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study. Eur Heart J 41(2):221–226 62. Lyall DM, Celis-Morales C, Ward J, Iliodromiti S, Anderson JJ, Gill JMR, Smith DJ, Ntuk UE, Mackay DF, Holmes MV et al (2017) Association of body mass index with cardiometabolic disease in the UK Biobank: a Mendelian randomization study. JAMA Cardiol 2(8):882–889 63. Lipscombe LL, Fischer HD, Yun L, Gruneir A, Austin P, Paszat L, Anderson GM, Rochon PA (2012) Association between tamoxifen treatment and diabetes. Cancer 118(10):2615–2622 64. Dewar JA, Horobin JM, Preece PE, Tavendale R, Tunstall-Pedoe H, Wood RA (1992) Long term effects of tamoxifen on blood lipid values in breast cancer. BMJ 305(6847):225–226 65. Liu C-L, Yang T-L (2003) Sequential changes in serum triglyceride levels during adjuvant tamoxifen therapy in breast cancer patients and the effect of dose reduction. Breast Cancer Res Treat 79(1):11–16 66. Klöting N, Kern M, Moruzzi M, Stumvoll M, Blüher M (2020) Tamoxifen treatment causes early hepatic insulin resistance. Acta Diabetol 57(4):495–498 67. Lai SW, Lin CL, Liao KF (2019) Association between tamoxifen use and acute myocardial infarction in women with breast cancer. Medicine (Baltim) 98(3):e13925 68. Pan H-J, Chang H-T, Lee C-H (2016) Association between tamoxifen treatment and the development of different stages of non-alcoholic fatty liver disease among breast cancer patients. J Formos Med Assoc 115(6):411–417 The original article has been corrected.